@article{93a26faf53f746a18678ea95e128b056,
title = "Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines",
author = "Benchimol, {Eric I.} and Frances Tse and Carroll, {Matthew W.} and deBruyn, {Jennifer C.} and McNeil, {Shelly A.} and Anne Pham-Huy and Seow, {Cynthia H.} and Barrett, {Lisa L.} and Talat Bessissow and Nicholas Carman and Melmed, {Gil Y.} and Vanderkooi, {Otto G.} and Marshall, {John K.} and Jones, {Jennifer L.}",
note = "Funding Information: Acknowledgments The Canadian Association of Gastroenterology (CAG) would like to thank the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism and Diabetes for their generous support of the guideline process. The consensus group would like to thank the following people for their contributions: Dr Dionne Duncan and Karen Sparkes (CAG representatives: administrative and technical support, and logistical assistance). The consensus group would also like to thank their patient/patient advocates, Claudia Tersigni, Thea Ewert, and Sara Croke, for their thoughtful input into the guideline process. Writing assistance: The consensus group would like to thank Pauline Lavigne and Steven Portelance (unaffiliated) who provided medical writing services on their behalf, supported by funds from the CAG. Author contributions: The co-chairs (Eric I. Benchimol, Jennifer L. Jones), steering committee (Anne Pham-Huy, Cynthia H. Seow, Jennifer C. deBruyn, and Shelly A. McNeil), and GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodologists (Frances Tse, Matthew W. Carroll) reviewed the literature and drafted the PICO (patient population, intervention, comparator, and outcome) questions. Frances Tse and Matthew W. Carroll assessed the evidence and provided GRADE evaluations. All members of the consensus group helped develop and voted on the direction and strength of the recommendations. The manuscript was initially drafted by the co-chairs (Eric I. Benchimol, Jennifer L. Jones) and Frances Tse, after which it was revised based on input from all members of the consensus group and the moderator (John K. Marshall). In addition, a patient with IBD reviewed the PICO questions and 2 patients provided input on the final manuscript. Funding Information: Funding This guideline was supported through unrestricted grants to the Canadian Association of Gastroenterology (CAG) by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes, and CANImmunize who had no involvement in any aspect of the guideline development or manuscript preparation. Eric I. Benchimol was supported by a New Investigator Award from the Canadian Institutes of Health Research, Crohn's and Colitis Canada, and CAG. He was also supported by the Career Enhancement Program of the Canadian Child Health Clinician Scientist Program. Acknowledgments The Canadian Association of Gastroenterology (CAG) would like to thank the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism and Diabetes for their generous support of the guideline process. The consensus group would like to thank the following people for their contributions: Dr Dionne Duncan and Karen Sparkes (CAG representatives: administrative and technical support, and logistical assistance). The consensus group would also like to thank their patient/patient advocates, Claudia Tersigni, Thea Ewert, and Sara Croke, for their thoughtful input into the guideline process. Writing assistance: The consensus group would like to thank Pauline Lavigne and Steven Portelance (unaffiliated) who provided medical writing services on their behalf, supported by funds from the CAG. Author contributions: The co-chairs (Eric I. Benchimol, Jennifer L. Jones), steering committee (Anne Pham-Huy, Cynthia H. Seow, Jennifer C. deBruyn, and Shelly A. McNeil), and GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodologists (Frances Tse, Matthew W. Carroll) reviewed the literature and drafted the PICO (patient population, intervention, comparator, and outcome) questions. Frances Tse and Matthew W. Carroll assessed the evidence and provided GRADE evaluations. All members of the consensus group helped develop and voted on the direction and strength of the recommendations. The manuscript was initially drafted by the co-chairs (Eric I. Benchimol, Jennifer L. Jones) and Frances Tse, after which it was revised based on input from all members of the consensus group and the moderator (John K. Marshall). In addition, a patient with IBD reviewed the PICO questions and 2 patients provided input on the final manuscript. Funding Information: Funding This guideline was supported through unrestricted grants to the Canadian Association of Gastroenterology (CAG) by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes , and CANImmunize who had no involvement in any aspect of the guideline development or manuscript preparation. Eric I. Benchimol was supported by a New Investigator Award from the Canadian Institutes of Health Research, Crohn{\textquoteright}s and Colitis Canada, and CAG. He was also supported by the Career Enhancement Program of the Canadian Child Health Clinician Scientist Program . Publisher Copyright: {\textcopyright} 2021",
year = "2021",
month = aug,
doi = "10.1053/j.gastro.2020.12.079",
language = "English",
volume = "161",
pages = "669--680.e0",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",
}
